Yang, J., Zhang, Y., Li, Q., & Wang, P. (2025). Sitravatinib combined with venetoclax exerts effective synergy to eliminate acute myeloid leukemia cells with FLT3-ITD mutations. Elsevier.
Chicago Style (17th ed.) CitationYang, Jie, Yvyin Zhang, Qingshan Li, and Peihong Wang. Sitravatinib Combined with Venetoclax Exerts Effective Synergy to Eliminate Acute Myeloid Leukemia Cells with FLT3-ITD Mutations. Elsevier, 2025.
MLA (9th ed.) CitationYang, Jie, et al. Sitravatinib Combined with Venetoclax Exerts Effective Synergy to Eliminate Acute Myeloid Leukemia Cells with FLT3-ITD Mutations. Elsevier, 2025.
Warning: These citations may not always be 100% accurate.